The LCK-14-3-3ζ-TRPM8 axis regulates TRPM8 function/assembly and promotes pancreatic cancer malignancy

Yuan Huang1, Shi Li1, Qinfeng Liu1

  • 1National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan, China.

Insights

Lymphocyte-specific protein tyrosine kinase (LCK) interacts with the TRPM8 channel, enhancing its function and promoting pancreatic cancer cell growth. This LCK-TRPM8 axis highlights new therapeutic targets for pancreatic cancer.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Transient receptor potential melastatin 8 (TRPM8) is a Ca2+-permeable channel implicated in diseases, including pancreatic cancer.
  • The precise mechanisms underlying TRPM8 dysfunction in disease remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular interactions and regulatory mechanisms of TRPM8.
  • To investigate the role of TRPM8 in pancreatic cancer progression.

Main Methods:

  • Co-immunoprecipitation assays to identify protein interactions.
  • Electrophysiology to measure TRPM8 channel activity.
  • Western blotting to assess protein phosphorylation and ubiquitination.
  • Cell proliferation, migration, and tumorigenesis assays in pancreatic cancer models.

Main Results:

  • Lymphocyte-specific protein tyrosine kinase (LCK) directly interacts with TRPM8 and enhances its channel activity by promoting phosphorylation at Y1022 and multimerization.
  • The 14-3-3ζ protein binds to TRPM8, modulating its multimerization, with LCK enhancing this interaction.
  • TRPM8 phosphorylation at Y1022 feedback regulates LCK activity.
  • TRPM8 phosphorylation at Y1022 is crucial for pancreatic cancer cell proliferation, migration, and tumorigenesis.

Conclusions:

  • The LCK-14-3-3ζ-TRPM8 signaling axis regulates TRPM8 assembly, channel function, and LCK activity.
  • This axis represents a potential therapeutic target for pancreatic cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K